Breast cancer treatment in clinical practice compared to best evidence and practice guidelines
Open Access
- 6 January 2004
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 90 (1) , 26-30
- https://doi.org/10.1038/sj.bjc.6601439
Abstract
There is sparse evidence on community practice patterns in treating women with breast cancer. This study compared care of women with breast cancer with evidence from meta-analyses and US National Comprehensive Cancer Network (NCCN) clinical guidelines. Records of 4395 women with breast cancer were abstracted from practices of 19 surgeon oncologists in six specialty practices in the Philadelphia region during 1995–1999. Patients were followed through December 2001. Low-frequency data were obtained on all patients. All other data were from a random sample of 464 women, minimum of 50 patients per practice. Actual care provided was compared to NCCN guidelines and results of meta-analyses. Fewer than half the women received treatments reflecting meta-analysis results or NCCN guidelines, by disease stage/TNM status. Adherence to either standard varied from 0% for LCIS to 87% for stages IIA or IIB node positive. There are multiple interactive reasons for low adherence to guidelines or meta-analyses results, including insufficient health system supports to clinicians, inadequate organisation and delivery systems and ineffective continuing medical education. The paucity of written information from patient records on physician/patient interactions limits the understanding of treatment decisions.Keywords
This publication has 33 references indexed in Scilit:
- Quality of Breast Cancer Care: What Do We Know?Journal of Clinical Oncology, 2002
- Psychological aspects of breast reconstruction: a review of the literatureJournal of Advanced Nursing, 2001
- Equitable access to cancer servicesCancer, 1999
- Cancer UndefeatedNew England Journal of Medicine, 1997
- Effects of Radiotherapy and Surgery in Early Breast Cancer — An Overview of the Randomized TrialsNew England Journal of Medicine, 1995
- Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 womenThe Lancet, 1992
- Effects of Adjuvant Tamoxifen and of Cytotoxic Therapy on Mortality in Early Breast CancerNew England Journal of Medicine, 1988
- Adjuvant chemotherapy for breast cancer. A pooled estimate based on published randomized control trialsJAMA, 1986
- The Psychological Impact of Immediate Breast Reconstruction for Women with Early Breast CancerPlastic and Reconstructive Surgery, 1984
- Patient Acceptance of Immediate Reconstruction Following MastectomyPlastic and Reconstructive Surgery, 1982